Study on Foot-and-Mouth Disease Virus Results in Submission for Additional EPA Label
- None.
- None.
Insights
An effective response to Transboundary Animal Diseases (TADs) like foot-and-mouth disease virus (FMDV) is crucial for maintaining the stability of agricultural economies and ensuring global food security. The recent study by TOMI Environmental Solutions demonstrating the virucidal efficacy of SteraMist iHP technology against FMDV on various surfaces represents a significant development in biosecurity measures. The ability to halt the transmission of such viruses is essential in preventing not only the spread of disease among livestock populations but also in averting the catastrophic economic consequences that can arise from outbreaks, which include loss of production, culling of animals and restrictions on international trade.
As the study meets EPA standards, it indicates a rigorous approach to validation, which is fundamental in gaining trust among stakeholders in the agricultural sector. The potential addition of an EPA label for TOMI's product could enhance its marketability and adoption in various sectors that require high standards of biosecurity, such as agriculture, pharmaceuticals and healthcare. The implications for stakeholders range from farmers, who could see a reduction in the risk of disease outbreaks, to investors, who might anticipate increased demand for TOMI's technologies.
The threat posed by FMDV to livestock is not only a matter of animal health but also of economic stability for those reliant on animal agriculture. The announcement of TOMI's SteraMist iHP technology's effectiveness in neutralizing FMDV carries implications for veterinary medicine and animal husbandry practices. With the potential for a new tool in the biosecurity arsenal, veterinarians and farmers could adopt more effective decontamination protocols, potentially reducing reliance on vaccines and other biosecurity measures that may be less effective or more costly.
Moreover, the ability of the technology to perform in the presence of organic soil load suggests its practical application in real-world farm environments, where cleanliness levels can be challenging to maintain. This could lead to a paradigm shift in how decontamination is approached in the industry, with an emphasis on technologies that can perform under less-than-ideal conditions.
The announcement of a new study validating the effectiveness of TOMI's disinfection technology against FMDV could have a notable impact on the company's market position. As TOMI seeks an additional EPA label, investors may view this as a positive indicator of the company's commitment to innovation and its potential for growth in the biosecurity market. This could affect TOMI's stock performance as markets respond to the company's expanding portfolio and the potential for increased sales and licensing opportunities.
It is important to note that the market for disinfection technologies is competitive, with many players vying for a share. TOMI's success will depend on its ability to differentiate its product, the speed at which it can bring its EPA-labeled product to market and its effectiveness in securing partnerships and sales contracts. The long-term impact on the business will hinge on the adoption rate of SteraMist iHP technology across the targeted industries and the company's ability to maintain a competitive edge through continuous innovation and effective marketing strategies.
FREDERICK, Md., March 11, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, announces a new groundbreaking study demonstrating the effectiveness of its solutions against foot-and-mouth disease virus (FMDV). This significant advancement supports the Company’s submission for an additional EPA label.
Foot-and-mouth disease (FMD) represents a critical global threat, being an extremely contagious disease affecting a wide range of cloven-hoofed animals including cows, pigs, sheep, goats, and deer. The rapid spread of FMDV among livestock can lead to significant economic losses and disrupt international trade if not promptly and effectively controlled.
TOMI’s recent study has proven SteraMist iHP technology to eliminate infectious FMDV from both porous (concrete) and non-porous (stainless steel) surfaces in the presence of organic soil load. This achievement meets the stringent EPA standards for demonstrating virucidal efficacy. The study, conducted by the Department of Homeland Security (DHS) Science and Technology Directorate’s (S&T’s) Plum Island Animal Disease Center (PIADC), adhered to the strict regulatory guidelines of the U.S. Select Agent Program and utilized methods aligned with EPA-approved testing standards.
Dr. Halden Shane, CEO of TOMI, emphasizes the critical nature of combating Transboundary Animal Disease (TAD) outbreaks, such as FMD, “These diseases not only disrupt domestic agricultural production but may also severely impact international trade of agricultural commodities. TADs have the potential to cause widespread economic and societal damage, particularly in regions where agricultural animals are a primary livelihood. Our mission extends into the food safety sector, aiming to halt the transmission of viruses and prevent cross-contamination. This latest study underscores our commitment to providing effective solutions in the fight against global animal diseases," Dr. Halden Shane remarked.
TOMI continues conducting research to strengthen its role as a crucial advocate for advancing global health and ensuring food safety, protecting against infectious diseases.
TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®
TOMI™ Environmental Solutions, Inc. (NASDAQ: TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology ® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage hydrogen peroxide as its only active ingredient and uses patented ionized Hydrogen Peroxide (iHP™) technology in all SteraMist systems to create superior disinfection. TOMI products are designed to service a broad spectrum of use sites, including, but not limited to, hospitals and medical facilities, biosafety labs, pharmaceutical facilities, commercial and office buildings, schools, restaurants, meat and produce processing facilities, and police and fire departments.
For additional information, please visit http://www.steramist.com/ or contact us at info@tomimist.com
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, statements relating to the ability of TOMI’s products to eliminate infectious diseases. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, the impact of COVID-19 pandemic on our business and customers; our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended March 2023 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.
INVESTOR RELATIONS CONTACT:
John Nesbett/Rosalyn Christian
IMS Investor Relations
tomi@imsinvestorrelations.com
FAQ
What is the ticker symbol for TOMI Environmental Solutions, Inc.?
What disease was the recent study focused on by TOMI Environmental Solutions, Inc.?
Who conducted the study demonstrating the effectiveness of TOMI's solutions against FMDV?
What technology did TOMI use to eliminate FMDV from surfaces?
What is the mission of TOMI Environmental Solutions, Inc.?
